Would CVS Pay Its Own Market Cap for Aetna?

At $205 per share, the transaction would cost $68 billion, close to CVS’s own $74 billion market capitalization.

Oct. 27, 2017 2:18 p.m. ET

Oct. 27, 2017 2:18 p.m. ET

Guggenheim Securities

According to media reports, CVS Health is in talks to acquire Aetna for more than $200 per share.

While we have no way of knowing the ultimate outcome of this situation, we would note that CVS (ticker: CVS) has been assembling a unique collection of prescription assets over the past decade and this would represent an...